Table 3

Direct medical costs with specified drug costs in the first 3 years after diagnosis, per patient (in US$)

	Direct medical cost (A)		Sum of all medication costs (B)		Percent-ages of B/A	Sum of anticancer drug cost (C)		Percentages of C/A
	Mean	Median	Mean	Median	Percent-ages of B/A	Mean	Median	Percentages of C/A
Cancer
Lung cancer	18 410	12 238	9181	2717	49.9	7641	832	41.5
Female breast cancer	13 946	9747	5903	1315	42.3	4667	371	33.5
Colorectal cancer	11 998	8427	3977	1304	33.1	2655	0	22.1
Liver cancer	10 759	7115	3140	877	29.2	1051	0	9.8
Oral cancer	19 644	17 525	2359	1217	12.0	638	15	3.2
Leukaemia	28 464	9001	17 169	2158	60.3	9969	85	35.0
Prostate cancer	11 170	8397	4197	2224	37.6	2575	615	23.1
Non-Hodgkin's lymphoma	18 050	14 003	7975	4206	44.2	4480	1275	24.8
Gastric cancer	11 883	8462	3923	1380	33.0	2188	0	18.4
Oesophageal cancer	19 816	17 815	2660	1706	13.4	294	44	1.5
Heart disease
Acute coronary syndrome	6031	4724	857	348	14.2	–	–	–

The median cost of anticancer drugs was zero because more than half of the patients did not receive anticancer drugs for cancer treatment.